Literature DB >> 15861473

A dispensable methoxy group? Phenyl fencholate as a chiral modifier of n-butyllithium.

B Goldfuss1, M Steigelmann, T Löschmann, G Schilling, F Rominger.   

Abstract

Phenyl fenchol forms a 3:1 aggregate with n-butyllithium (3-BuLi), showing unique lithium-HC agostic interactions both in toluene solution (1H,7Li-HOESY) and in the solid state (X-ray analysis). Although methoxy-lithium coordination is characteristic for many mixed aggregates of anisyl fencholates with n-butyllithium, endo-methyl coordination to lithium ions compensates for the missing methoxy groups in 3-BuLi. This gives rise to a different orientation of the fenchane moiety, encapsulating and chirally modifying the butylide unit.

Entities:  

Year:  2005        PMID: 15861473     DOI: 10.1002/chem.200500158

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  4 in total

1.  An exceptional P-H phosphonite: biphenyl-2,2'-bisfenchylchlorophosphite and derived ligands (BIFOPs) in enantioselective copper-catalyzed 1,4-additions.

Authors:  T Kop-Weiershausen; J Lex; J-M Neudörfl; B Goldfuss
Journal:  Beilstein J Org Chem       Date:  2005-08-26       Impact factor: 2.883

2.  A superior P-H phosphonite: asymmetric allylic substitutions with fenchol-based palladium catalysts.

Authors:  Bernd Goldfuss; Thomas Löschmann; Tina Kop-Weiershausen; Jörg Neudörfl; Frank Rominger
Journal:  Beilstein J Org Chem       Date:  2006-03-30       Impact factor: 2.883

3.  An unusually stable chlorophosphite: What makes BIFOP-Cl so robust against hydrolysis?

Authors:  Roberto Blanco Trillo; Jörg M Neudörfl; Bernd Goldfuss
Journal:  Beilstein J Org Chem       Date:  2015-03-04       Impact factor: 2.883

4.  Control of asymmetric biaryl conformations with terpenol moieties: syntheses, structures and energetics of new enantiopure C2-symmetric diols.

Authors:  Y Alpagut; B Goldfuss; J-M Neudörfl
Journal:  Beilstein J Org Chem       Date:  2008-07-10       Impact factor: 2.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.